Abstract
There is now good evidence to demonstrate that aberrations in tumour necrosis factor (TNF) production in vivo may be either pathogenic or protective and several plausible mechanisms may explain these contrasting activities. According to the classic pro-inflammatory scenario, failure to regulate the production of TNF at a site of immunological injury may lead to chronic activation of innate immune cells and to chronic inflammatory responses, which may consequently lead to organ specific inflammatory pathology and tissue damage. However, more cryptic functions of this molecule may be considered to play a significant part in the development of TNF mediated pathologies. Direct interference of TNF with the differentiation, proliferation or death of specific pathogenic cell targets may be an alternative mechanism for disease initiation or progression. In addition to these activities, there is now considerable evidence to suggest that TNF may also directly promote or down regulate the adaptive immune response. A more complete understanding of the temporal and spatial context of TNF/TNF receptor (TNF-R) function and of the molecular and cellular pathways leading to the development of TNF/TNF-R mediated pathologies is necessary to fully comprehend relevant mechanisms of disease induction and progression in humans. In this paper, the potential pathogenic mechanisms exerted by TNF and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease are discussed. Elucidating the nature and level of contribution of these mechanisms in chronic inflammation and autoimmunity may lead to better regulatory and therapeutic applications.
Full Text
The Full Text of this article is available as a PDF (104.3 KB).
Figure 1 .
The diverse in vivo functions of TNF may significantly depend on the duration, quantity and quality of TNF signals. In addition, genetic background, locality and timing of TNF expression may also modulate the function of this molecule and diversify the end result of the immune response, either to the benefit or distress of the host.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aderka D., Sorkine P., Abu-Abid S., Lev D., Setton A., Cope A. P., Wallach D., Klausner J. Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock. J Clin Invest. 1998 Feb 1;101(3):650–659. doi: 10.1172/JCI694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev. 1996 Oct;7(3):231–240. doi: 10.1016/s1359-6101(96)00026-3. [DOI] [PubMed] [Google Scholar]
- Aggarwal B. B., Natarajan K. Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw. 1996 Apr-Jun;7(2):93–124. [PubMed] [Google Scholar]
- Akassoglou K., Bauer J., Kassiotis G., Pasparakis M., Lassmann H., Kollias G., Probert L. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol. 1998 Sep;153(3):801–813. doi: 10.1016/S0002-9440(10)65622-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Akassoglou K., Probert L., Kontogeorgos G., Kollias G. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol. 1997 Jan 1;158(1):438–445. [PubMed] [Google Scholar]
- Baker D., Butler D., Scallon B. J., O'Neill J. K., Turk J. L., Feldmann M. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur J Immunol. 1994 Sep;24(9):2040–2048. doi: 10.1002/eji.1830240916. [DOI] [PubMed] [Google Scholar]
- Becher B., Blain M., Giacomini P. S., Antel J. P. Inhibition of Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12. J Immunol. 1999 Jan 15;162(2):684–688. [PubMed] [Google Scholar]
- Bessis N., Chiocchia G., Kollias G., Minty A., Fournier C., Fradelizi D., Boissier M. C. Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13. Clin Exp Immunol. 1998 Feb;111(2):391–396. doi: 10.1046/j.1365-2249.1998.00500.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boldin M. P., Mett I. L., Varfolomeev E. E., Chumakov I., Shemer-Avni Y., Camonis J. H., Wallach D. Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J Biol Chem. 1995 Jan 6;270(1):387–391. doi: 10.1074/jbc.270.1.387. [DOI] [PubMed] [Google Scholar]
- Butler D. M., Piccoli D. S., Hart P. H., Hamilton J. A. Stimulation of human synovial fibroblast DNA synthesis by recombinant human cytokines. J Rheumatol. 1988 Oct;15(10):1463–1470. [PubMed] [Google Scholar]
- Carlos T. M., Harlan J. M. Leukocyte-endothelial adhesion molecules. Blood. 1994 Oct 1;84(7):2068–2101. [PubMed] [Google Scholar]
- Cheng G., Baltimore D. TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation. Genes Dev. 1996 Apr 15;10(8):963–973. doi: 10.1101/gad.10.8.963. [DOI] [PubMed] [Google Scholar]
- Chiocchia G., Boissier M. C., Fournier C. Therapy against murine collagen-induced arthritis with T cell receptor V beta-specific antibodies. Eur J Immunol. 1991 Dec;21(12):2899–2905. doi: 10.1002/eji.1830211202. [DOI] [PubMed] [Google Scholar]
- Cope A. P., Aderka D., Doherty M., Engelmann H., Gibbons D., Jones A. C., Brennan F. M., Maini R. N., Wallach D., Feldmann M. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum. 1992 Oct;35(10):1160–1169. doi: 10.1002/art.1780351008. [DOI] [PubMed] [Google Scholar]
- Cope A. P., Liblau R. S., Yang X. D., Congia M., Laudanna C., Schreiber R. D., Probert L., Kollias G., McDevitt H. O. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med. 1997 May 5;185(9):1573–1584. doi: 10.1084/jem.185.9.1573. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cope A., Ettinger R., McDevitt H. The role of TNF alpha and related cytokines in the development and function of the autoreactive T-cell repertoire. Res Immunol. 1997 Jun;148(5):307–312. doi: 10.1016/s0923-2494(97)87239-2. [DOI] [PubMed] [Google Scholar]
- Dayer J. M., Beutler B., Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med. 1985 Dec 1;162(6):2163–2168. doi: 10.1084/jem.162.6.2163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Diez-Ruiz A., Tilz G. P., Zangerle R., Baier-Bitterlich G., Wachter H., Fuchs D. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol. 1995 Jan;54(1):1–8. doi: 10.1111/j.1600-0609.1995.tb01618.x. [DOI] [PubMed] [Google Scholar]
- Douni E., Akassoglou K., Alexopoulou L., Georgopoulos S., Haralambous S., Hill S., Kassiotis G., Kontoyiannis D., Pasparakis M., Plows D. Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis. J Inflamm. 1995;47(1-2):27–38. [PubMed] [Google Scholar]
- Douni E., Kollias G. A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin alpha, or the p55TNF-R. J Exp Med. 1998 Oct 5;188(7):1343–1352. doi: 10.1084/jem.188.7.1343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Erickson S. L., de Sauvage F. J., Kikly K., Carver-Moore K., Pitts-Meek S., Gillett N., Sheehan K. C., Schreiber R. D., Goeddel D. V., Moore M. W. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature. 1994 Dec 8;372(6506):560–563. doi: 10.1038/372560a0. [DOI] [PubMed] [Google Scholar]
- Feldmann M., Brennan F. M., Maini R. N. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397–440. doi: 10.1146/annurev.immunol.14.1.397. [DOI] [PubMed] [Google Scholar]
- Firestein G. S. Starving the synovium: angiogenesis and inflammation in rheumatoid arthritis. J Clin Invest. 1999 Jan;103(1):3–4. doi: 10.1172/JCI5929. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fisher C. J., Jr, Agosti J. M., Opal S. M., Lowry S. F., Balk R. A., Sadoff J. C., Abraham E., Schein R. M., Benjamin E. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med. 1996 Jun 27;334(26):1697–1702. doi: 10.1056/NEJM199606273342603. [DOI] [PubMed] [Google Scholar]
- Flory C. M., Jones M. L., Miller B. F., Warren J. S. Regulatory roles of tumor necrosis factor-alpha and interleukin-1 beta in monocyte chemoattractant protein-1-mediated pulmonary granuloma formation in the rat. Am J Pathol. 1995 Feb;146(2):450–462. [PMC free article] [PubMed] [Google Scholar]
- Fritz R. B., Kalvakolanu I. Thymic expression of the golli-myelin basic protein gene in the SJL/J mouse. J Neuroimmunol. 1995 Mar;57(1-2):93–99. doi: 10.1016/0165-5728(94)00167-m. [DOI] [PubMed] [Google Scholar]
- Gabay C., Cakir N., Moral F., Roux-Lombard P., Meyer O., Dayer J. M., Vischer T., Yazici H., Guerne P. A. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J Rheumatol. 1997 Feb;24(2):303–308. [PubMed] [Google Scholar]
- Geiler T., Kriegsmann J., Keyszer G. M., Gay R. E., Gay S. A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice. Arthritis Rheum. 1994 Nov;37(11):1664–1671. doi: 10.1002/art.1780371116. [DOI] [PubMed] [Google Scholar]
- Goldschmidt T. J., Holmdahl R. Anti-T cell receptor antibody treatment of rats with established autologous collagen-induced arthritis: suppression of arthritis without reduction of anti-type II collagen autoantibody levels. Eur J Immunol. 1991 May;21(5):1327–1330. doi: 10.1002/eji.1830210536. [DOI] [PubMed] [Google Scholar]
- Grau G. E., Maennel D. N. TNF inhibition and sepsis -- sounding a cautionary note. Nat Med. 1997 Nov;3(11):1193–1195. doi: 10.1038/nm1197-1193. [DOI] [PubMed] [Google Scholar]
- Green E. A., Eynon E. E., Flavell R. A. Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity. 1998 Nov;9(5):733–743. doi: 10.1016/s1074-7613(00)80670-6. [DOI] [PubMed] [Google Scholar]
- Grell M., Douni E., Wajant H., Löhden M., Clauss M., Maxeiner B., Georgopoulos S., Lesslauer W., Kollias G., Pfizenmaier K. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell. 1995 Dec 1;83(5):793–802. doi: 10.1016/0092-8674(95)90192-2. [DOI] [PubMed] [Google Scholar]
- Grell M., Wajant H., Zimmermann G., Scheurich P. The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):570–575. doi: 10.1073/pnas.95.2.570. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harrington C. J., Paez A., Hunkapiller T., Mannikko V., Brabb T., Ahearn M., Beeson C., Goverman J. Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. Immunity. 1998 May;8(5):571–580. doi: 10.1016/s1074-7613(00)80562-2. [DOI] [PubMed] [Google Scholar]
- Herbein G., Mahlknecht U., Batliwalla F., Gregersen P., Pappas T., Butler J., O'Brien W. A., Verdin E. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature. 1998 Sep 10;395(6698):189–194. doi: 10.1038/26026. [DOI] [PubMed] [Google Scholar]
- Heyman M., Darmon N., Dupont C., Dugas B., Hirribaren A., Blaton M. A., Desjeux J. F. Mononuclear cells from infants allergic to cow's milk secrete tumor necrosis factor alpha, altering intestinal function. Gastroenterology. 1994 Jun;106(6):1514–1523. doi: 10.1016/0016-5085(94)90405-7. [DOI] [PubMed] [Google Scholar]
- Hober D., Benyoucef S., Delannoy A. S., de Groote D., Ajana F., Mouton Y., Wattré P. High plasma level of soluble tumor necrosis factor receptor type II (sTNFRII) in asymptomatic HIV-1-infected patients. Infection. 1996 May-Jun;24(3):213–217. doi: 10.1007/BF01781095. [DOI] [PubMed] [Google Scholar]
- Hofman F. M., Hinton D. R., Johnson K., Merrill J. E. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med. 1989 Aug 1;170(2):607–612. doi: 10.1084/jem.170.2.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holmdahl R., Klareskog L., Rubin K., Larsson E., Wigzell H. T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand J Immunol. 1985 Sep;22(3):295–306. doi: 10.1111/j.1365-3083.1985.tb01884.x. [DOI] [PubMed] [Google Scholar]
- Kaiser G. C., Polk D. B. Tumor necrosis factor alpha regulates proliferation in a mouse intestinal cell line. Gastroenterology. 1997 Apr;112(4):1231–1240. doi: 10.1016/s0016-5085(97)70135-5. [DOI] [PubMed] [Google Scholar]
- Kassiotis G., Bauer J., Akassoglou K., Lassmann H., Kollias G., Probert L. A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient mice. Eur J Immunol. 1999 Mar;29(3):912–917. doi: 10.1002/(SICI)1521-4141(199903)29:03<912::AID-IMMU912>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
- Kassiotis G., Pasparakis M., Kollias G., Probert L. TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis. Eur J Immunol. 1999 Mar;29(3):774–780. doi: 10.1002/(SICI)1521-4141(199903)29:03<774::AID-IMMU774>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
- Katsikis P. D., Chu C. Q., Brennan F. M., Maini R. N., Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med. 1994 May 1;179(5):1517–1527. doi: 10.1084/jem.179.5.1517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Keffer J., Probert L., Cazlaris H., Georgopoulos S., Kaslaris E., Kioussis D., Kollias G. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 1991 Dec;10(13):4025–4031. doi: 10.1002/j.1460-2075.1991.tb04978.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kontoyiannis D., Pasparakis M., Pizarro T. T., Cominelli F., Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity. 1999 Mar;10(3):387–398. doi: 10.1016/s1074-7613(00)80038-2. [DOI] [PubMed] [Google Scholar]
- Kuiper S., Joosten L. A., Bendele A. M., Edwards C. K., 3rd, Arntz O. J., Helsen M. M., Van de Loo F. A., Van den Berg W. B. Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis. Cytokine. 1998 Sep;10(9):690–702. doi: 10.1006/cyto.1998.0372. [DOI] [PubMed] [Google Scholar]
- Körner H., Riminton D. S., Strickland D. H., Lemckert F. A., Pollard J. D., Sedgwick J. D. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J Exp Med. 1997 Nov 3;186(9):1585–1590. doi: 10.1084/jem.186.9.1585. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Küsters S., Tiegs G., Alexopoulou L., Pasparakis M., Douni E., Künstle G., Bluethmann H., Wendel A., Pfizenmaier K., Kollias G. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur J Immunol. 1997 Nov;27(11):2870–2875. doi: 10.1002/eji.1830271119. [DOI] [PubMed] [Google Scholar]
- Le Hir M., Bluethmann H., Kosco-Vilbois M. H., Müller M., di Padova F., Moore M., Ryffel B., Eugster H. P. Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J Exp Med. 1996 May 1;183(5):2367–2372. doi: 10.1084/jem.183.5.2367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Llewellyn-Smith N., Lai M., Miller D. H., Rudge P., Thompson A. J., Cuzner M. L. Effects of anti-CD4 antibody treatment on lymphocyte subsets and stimulated tumor necrosis factor alpha production: a study of 29 multiple sclerosis patients entered into a clinical trial of cM-T412. Neurology. 1997 Apr;48(4):810–816. doi: 10.1212/wnl.48.4.810. [DOI] [PubMed] [Google Scholar]
- Lucas R., Juillard P., Decoster E., Redard M., Burger D., Donati Y., Giroud C., Monso-Hinard C., De Kesel T., Buurman W. A. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur J Immunol. 1997 Jul;27(7):1719–1725. doi: 10.1002/eji.1830270719. [DOI] [PubMed] [Google Scholar]
- Lucas R., Lou J., Morel D. R., Ricou B., Suter P. M., Grau G. E. TNF receptors in the microvascular pathology of acute respiratory distress syndrome and cerebral malaria. J Leukoc Biol. 1997 May;61(5):551–558. doi: 10.1002/jlb.61.5.551. [DOI] [PubMed] [Google Scholar]
- Marinos G., Naoumov N. V., Rossol S., Torre F., Wong P. Y., Gallati H., Portmann B., Williams R. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. Gastroenterology. 1995 May;108(5):1453–1463. doi: 10.1016/0016-5085(95)90694-0. [DOI] [PubMed] [Google Scholar]
- Mencacci A., Cenci E., Del Sero G., Fè d'Ostiani C., Mosci P., Montagnoli C., Bacci A., Bistoni F., Quesniaux V. F., Ryffel B. Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-alpha double-deficient mice infected with Candida albicans. Int Immunol. 1998 Jan;10(1):37–48. doi: 10.1093/intimm/10.1.37. [DOI] [PubMed] [Google Scholar]
- Miossec P., Naviliat M., Dupuy d'Angeac A., Sany J., Banchereau J. Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid synovitis. Arthritis Rheum. 1990 Aug;33(8):1180–1187. doi: 10.1002/art.1780330819. [DOI] [PubMed] [Google Scholar]
- Moreland L. W., Pratt P. W., Mayes M. D., Postlethwaite A., Weisman M. H., Schnitzer T., Lightfoot R., Calabrese L., Zelinger D. J., Woody J. N. Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate. Arthritis Rheum. 1995 Nov;38(11):1581–1588. doi: 10.1002/art.1780381109. [DOI] [PubMed] [Google Scholar]
- Mori L., Iselin S., De Libero G., Lesslauer W. Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice. J Immunol. 1996 Oct 1;157(7):3178–3182. [PubMed] [Google Scholar]
- Müller-Ladner U., Kriegsmann J., Franklin B. N., Matsumoto S., Geiler T., Gay R. E., Gay S. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol. 1996 Nov;149(5):1607–1615. [PMC free article] [PubMed] [Google Scholar]
- Nashleanas M., Kanaly S., Scott P. Control of Leishmania major infection in mice lacking TNF receptors. J Immunol. 1998 Jun 1;160(11):5506–5513. [PubMed] [Google Scholar]
- Neurath M. F., Fuss I., Pasparakis M., Alexopoulou L., Haralambous S., Meyer zum Büschenfelde K. H., Strober W., Kollias G. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol. 1997 Jul;27(7):1743–1750. doi: 10.1002/eji.1830270722. [DOI] [PubMed] [Google Scholar]
- Olsen N. J., Brooks R. H., Cush J. J., Lipsky P. E., St Clair E. W., Matteson E. L., Gold K. N., Cannon G. W., Jackson C. G., McCune W. J. A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis. The Xoma RA Investigator Group. Arthritis Rheum. 1996 Jul;39(7):1102–1108. doi: 10.1002/art.1780390705. [DOI] [PubMed] [Google Scholar]
- Pasparakis M., Alexopoulou L., Episkopou V., Kollias G. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med. 1996 Oct 1;184(4):1397–1411. doi: 10.1084/jem.184.4.1397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pender S. L., Fell J. M., Chamow S. M., Ashkenazi A., MacDonald T. T. A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase production. J Immunol. 1998 Apr 15;160(8):4098–4103. [PubMed] [Google Scholar]
- Pfeffer K., Matsuyama T., Kündig T. M., Wakeham A., Kishihara K., Shahinian A., Wiegmann K., Ohashi P. S., Krönke M., Mak T. W. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 1993 May 7;73(3):457–467. doi: 10.1016/0092-8674(93)90134-c. [DOI] [PubMed] [Google Scholar]
- Philip R., Epstein L. B. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature. 1986 Sep 4;323(6083):86–89. doi: 10.1038/323086a0. [DOI] [PubMed] [Google Scholar]
- Piguet P. F., Vesin C., Guo J., Donati Y., Barazzone C. TNF-induced enterocyte apoptosis in mice is mediated by the TNF receptor 1 and does not require p53. Eur J Immunol. 1998 Nov;28(11):3499–3505. doi: 10.1002/(SICI)1521-4141(199811)28:11<3499::AID-IMMU3499>3.0.CO;2-Q. [DOI] [PubMed] [Google Scholar]
- Plevy S. E., Landers C. J., Prehn J., Carramanzana N. M., Deem R. L., Shealy D., Targan S. R. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol. 1997 Dec 15;159(12):6276–6282. [PubMed] [Google Scholar]
- Plows D., Kontogeorgos G., Kollias G. Mice lacking mature T and B lymphocytes develop arthritic lesions after immunization with type II collagen. J Immunol. 1999 Jan 15;162(2):1018–1023. [PubMed] [Google Scholar]
- Podolsky D. K. Inflammatory bowel disease (1) N Engl J Med. 1991 Sep 26;325(13):928–937. doi: 10.1056/NEJM199109263251306. [DOI] [PubMed] [Google Scholar]
- Powrie F., Leach M. W., Mauze S., Menon S., Caddle L. B., Coffman R. L. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity. 1994 Oct;1(7):553–562. doi: 10.1016/1074-7613(94)90045-0. [DOI] [PubMed] [Google Scholar]
- Probert L., Akassoglou K., Pasparakis M., Kontogeorgos G., Kollias G. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11294–11298. doi: 10.1073/pnas.92.24.11294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Probert L., Keffer J., Corbella P., Cazlaris H., Patsavoudi E., Stephens S., Kaslaris E., Kioussis D., Kollias G. Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. J Immunol. 1993 Aug 15;151(4):1894–1906. [PubMed] [Google Scholar]
- Probert L., Plows D., Kontogeorgos G., Kollias G. The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice. Eur J Immunol. 1995 Jun;25(6):1794–1797. doi: 10.1002/eji.1830250647. [DOI] [PubMed] [Google Scholar]
- Rabizadeh S., Oh J., Zhong L. T., Yang J., Bitler C. M., Butcher L. L., Bredesen D. E. Induction of apoptosis by the low-affinity NGF receptor. Science. 1993 Jul 16;261(5119):345–348. doi: 10.1126/science.8332899. [DOI] [PubMed] [Google Scholar]
- Rao P., Hsu K. C., Chao M. V. Upregulation of NF-kappa B-dependent gene expression mediated by the p75 tumor necrosis factor receptor. J Interferon Cytokine Res. 1995 Feb;15(2):171–177. doi: 10.1089/jir.1995.15.171. [DOI] [PubMed] [Google Scholar]
- Rathanaswami P., Hachicha M., Wong W. L., Schall T. J., McColl S. R. Synergistic effect of interleukin-1 beta and tumor necrosis factor alpha on interleukin-8 gene expression in synovial fibroblasts. Evidence that interleukin-8 is the major neutrophil-activating chemokine released in response to monokine activation. Arthritis Rheum. 1993 Sep;36(9):1295–1304. doi: 10.1002/art.1780360914. [DOI] [PubMed] [Google Scholar]
- Robbins D. S., Shirazi Y., Drysdale B. E., Lieberman A., Shin H. S., Shin M. L. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol. 1987 Oct 15;139(8):2593–2597. [PubMed] [Google Scholar]
- Rothe J., Lesslauer W., Lötscher H., Lang Y., Koebel P., Köntgen F., Althage A., Zinkernagel R., Steinmetz M., Bluethmann H. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature. 1993 Aug 26;364(6440):798–802. doi: 10.1038/364798a0. [DOI] [PubMed] [Google Scholar]
- Rothe M., Sarma V., Dixit V. M., Goeddel D. V. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science. 1995 Sep 8;269(5229):1424–1427. doi: 10.1126/science.7544915. [DOI] [PubMed] [Google Scholar]
- Ruby J., Bluethmann H., Peschon J. J. Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors. J Exp Med. 1997 Nov 3;186(9):1591–1596. doi: 10.1084/jem.186.9.1591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ruddle N. H., Bergman C. M., McGrath K. M., Lingenheld E. G., Grunnet M. L., Padula S. J., Clark R. B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med. 1990 Oct 1;172(4):1193–1200. doi: 10.1084/jem.172.4.1193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rudin W., Eugster H. P., Bordmann G., Bonato J., Müller M., Yamage M., Ryffel B. Resistance to cerebral malaria in tumor necrosis factor-alpha/beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response. Am J Pathol. 1997 Jan;150(1):257–266. [PMC free article] [PubMed] [Google Scholar]
- Sankey E. A., Dhillon A. P., Anthony A., Wakefield A. J., Sim R., More L., Hudson M., Sawyerr A. M., Pounder R. E. Early mucosal changes in Crohn's disease. Gut. 1993 Mar;34(3):375–381. doi: 10.1136/gut.34.3.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Santee S. M., Owen-Schaub L. B. Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization. J Biol Chem. 1996 Aug 30;271(35):21151–21159. doi: 10.1074/jbc.271.35.21151. [DOI] [PubMed] [Google Scholar]
- Schröder J., Stüber F., Gallati H., Schade F. U., Kremer B. Pattern of soluble TNF receptors I and II in sepsis. Infection. 1995 May-Jun;23(3):143–148. doi: 10.1007/BF01793854. [DOI] [PubMed] [Google Scholar]
- Sean Riminton D., Körner H., Strickland D. H., Lemckert F. A., Pollard J. D., Sedgwick J. D. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J Exp Med. 1998 May 4;187(9):1517–1528. doi: 10.1084/jem.187.9.1517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Selmaj K. W., Raine C. S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol. 1988 Apr;23(4):339–346. doi: 10.1002/ana.410230405. [DOI] [PubMed] [Google Scholar]
- Sharief M. K., Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med. 1991 Aug 15;325(7):467–472. doi: 10.1056/NEJM199108153250704. [DOI] [PubMed] [Google Scholar]
- Shaw M. K., Kim C., Hao H. W., Chen F., Tse H. Y. Induction of myelin basic protein-specific experimental autoimmune encephalomyelitis in C57BL/6 mice: mapping of T cell epitopes and T cell receptor V beta gene segment usage. J Neurosci Res. 1996 Sep 15;45(6):690–699. doi: 10.1002/(SICI)1097-4547(19960915)45:6<690::AID-JNR5>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
- Shibuya K., Robinson D., Zonin F., Hartley S. B., Macatonia S. E., Somoza C., Hunter C. A., Murphy K. M., O'Garra A. IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice. J Immunol. 1998 Feb 15;160(4):1708–1716. [PubMed] [Google Scholar]
- Slowik M. R., De Luca L. G., Fiers W., Pober J. S. Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. Am J Pathol. 1993 Dec;143(6):1724–1730. [PMC free article] [PubMed] [Google Scholar]
- Speiser D. E., Sebzda E., Ohteki T., Bachmann M. F., Pfeffer K., Mak T. W., Ohashi P. S. Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur J Immunol. 1996 Dec;26(12):3055–3060. doi: 10.1002/eji.1830261235. [DOI] [PubMed] [Google Scholar]
- Stastny P. HLA-D and Ia antigens in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 1978 Jun;21(5 Suppl):S139–S143. doi: 10.1002/art.1780210921. [DOI] [PubMed] [Google Scholar]
- Strober W., Fuss I. J., Ehrhardt R. O., Neurath M., Boirivant M., Lúdvíksson B. R. Mucosal immunoregulation and inflammatory bowel disease: new insights from murine models of inflammation. Scand J Immunol. 1998 Nov;48(5):453–458. [PubMed] [Google Scholar]
- Strober W., Kelsall B., Fuss I., Marth T., Ludviksson B., Ehrhardt R., Neurath M. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today. 1997 Feb;18(2):61–64. doi: 10.1016/s0167-5699(97)01000-1. [DOI] [PubMed] [Google Scholar]
- Tada Y., Ho A., Koh D. R., Mak T. W. Collagen-induced arthritis in CD4- or CD8-deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J Immunol. 1996 Jun 1;156(11):4520–4526. [PubMed] [Google Scholar]
- Targan S. R., Hanauer S. B., van Deventer S. J., Mayer L., Present D. H., Braakman T., DeWoody K. L., Schaible T. F., Rutgeerts P. J. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med. 1997 Oct 9;337(15):1029–1035. doi: 10.1056/NEJM199710093371502. [DOI] [PubMed] [Google Scholar]
- Targoni O. S., Lehmann P. V. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J Exp Med. 1998 Jun 15;187(12):2055–2063. doi: 10.1084/jem.187.12.2055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tartaglia L. A., Goeddel D. V., Reynolds C., Figari I. S., Weber R. F., Fendly B. M., Palladino M. A., Jr Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J Immunol. 1993 Nov 1;151(9):4637–4641. [PubMed] [Google Scholar]
- Tartaglia L. A., Pennica D., Goeddel D. V. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem. 1993 Sep 5;268(25):18542–18548. [PubMed] [Google Scholar]
- Tartaglia L. A., Weber R. F., Figari I. S., Reynolds C., Palladino M. A., Jr, Goeddel D. V. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9292–9296. doi: 10.1073/pnas.88.20.9292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Van Deventer S. J. Tumour necrosis factor and Crohn's disease. Gut. 1997 Apr;40(4):443–448. doi: 10.1136/gut.40.4.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vandenabeele P., Declercq W., Beyaert R., Fiers W. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol. 1995 Oct;5(10):392–399. doi: 10.1016/s0962-8924(00)89088-1. [DOI] [PubMed] [Google Scholar]
- Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol. 1992;10:411–452. doi: 10.1146/annurev.iy.10.040192.002211. [DOI] [PubMed] [Google Scholar]
- Wang B., Fujisawa H., Zhuang L., Kondo S., Shivji G. M., Kim C. S., Mak T. W., Sauder D. N. Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J Immunol. 1997 Dec 15;159(12):6148–6155. [PubMed] [Google Scholar]
- Watkins P. E., Warren B. F., Stephens S., Ward P., Foulkes R. Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha. Gut. 1997 May;40(5):628–633. doi: 10.1136/gut.40.5.628. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yuan J. Transducing signals of life and death. Curr Opin Cell Biol. 1997 Apr;9(2):247–251. doi: 10.1016/s0955-0674(97)80069-5. [DOI] [PubMed] [Google Scholar]
- Zhan Y., Cheers C. Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors. J Immunol. 1998 Aug 1;161(3):1447–1453. [PubMed] [Google Scholar]
- Zheng L., Fisher G., Miller R. E., Peschon J., Lynch D. H., Lenardo M. J. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature. 1995 Sep 28;377(6547):348–351. doi: 10.1038/377348a0. [DOI] [PubMed] [Google Scholar]
- de Beaux A. C., Goldie A. S., Ross J. A., Carter D. C., Fearon K. C. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg. 1996 Mar;83(3):349–353. doi: 10.1002/bjs.1800830317. [DOI] [PubMed] [Google Scholar]
- de Kossodo S., Critico B., Grau G. E. Modulation of the transcripts for tumor necrosis factor-alpha and its receptors in vivo. Eur J Immunol. 1994 Mar;24(3):769–772. doi: 10.1002/eji.1830240342. [DOI] [PubMed] [Google Scholar]
- van Oosten B. W., Barkhof F., Truyen L., Boringa J. B., Bertelsmann F. W., von Blomberg B. M., Woody J. N., Hartung H. P., Polman C. H. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology. 1996 Dec;47(6):1531–1534. doi: 10.1212/wnl.47.6.1531. [DOI] [PubMed] [Google Scholar]